Charles River, WuXi PharmaTech CEOs Issue Joint Appeal For Shareholder Support
This article was originally published in The Pink Sheet Daily
Executive Summary
A shadow of suspense is expanding during the countdown to the dual shareholder meetings, since a New York-based money management firm that holds 7 percent of Charles River stock called for the abandonment of the merger plan weeks after it was unveiled in April..